{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:13:31Z","timestamp":1790039611573,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2345,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1124\/dmd.118.081844","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T13:25:02Z","timestamp":1528464302000},"page":"1191-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Three Faces of Mercaptopurine Cytotoxicity In Vitro: Methylation, Nucleotide Homeostasis, and Deoxythioguanosine in DNA"],"prefix":"10.1016","volume":"46","author":[{"given":"Sally A.","family":"Coulthard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McGarrity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalvin","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-8048","authenticated-orcid":false,"given":"Chris P.F.","family":"Redfern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.081844_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0006-2952(71)90046-3","article-title":"6-Methylthioguanylic acid, a metabolite of 6-thioguanine","volume":"20","author":"Allan","year":"1971","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0006-2952(93)90045-X","article-title":"6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts","volume":"45","author":"B\u00f6kkerink","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib3","first-page":"18","article-title":"Mechanism of thiopurine action","volume":"58","author":"Coulthard","year":"2012","journal-title":"Assoc Med Bras"},{"key":"10.1124\/dmd.118.081844_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jchromb.2016.06.017","article-title":"Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients","volume":"1028","author":"Coulthard","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.118.081844_bib4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/MIB.0000000000001131","article-title":"Azathioprine with allopurinol: lower deoxythioguanosine in DNA and transcriptome changes indicate mechanistic differences to azathioprine alone","volume":"23","author":"Coulthard","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/dmd.118.081844_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10637-005-4020-8","article-title":"The thiopurines: an update","volume":"23","author":"Coulthard","year":"2005","journal-title":"Invest New Drugs"},{"key":"10.1124\/dmd.118.081844_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.62.1.102","article-title":"The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs","volume":"62","author":"Coulthard","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/1535-7163.MCT-10-0798","article-title":"Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers","volume":"10","author":"Coulthard","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.118.081844_bib8","first-page":"5810","article-title":"Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells","volume":"61","author":"Dervieux","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.118.081844_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.ftd.0000169061.52715.3e","article-title":"Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides","volume":"27","author":"Duley","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.118.081844_bib10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jcph.81","article-title":"Incorporation of 6-thioguanine nucleotides into DNA during maintenance therapy of childhood acute lymphoblastic leukemia-the influence of thiopurine methyltransferase genotypes","volume":"53","author":"Ebbesen","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/ctrv.2002.0245","article-title":"Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine","volume":"27","author":"Estlin","year":"2001","journal-title":"Cancer Treat Rev"},{"key":"10.1124\/dmd.118.081844_bib12","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1016\/0006-2952(86)90623-4","article-title":"Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatment","volume":"35","author":"Fairchild","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib13","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bcp.2010.01.006","article-title":"Thiopurines: factors influencing toxicity and response","volume":"79","author":"Fotoohi","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-009-1184-5","article-title":"DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma","volume":"66","author":"Hedeland","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bcp.2008.07.026","article-title":"The effect of thiopurine drugs on DNA methylation in relation to TPMT expression","volume":"76","author":"Hogarth","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib16","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI--a COmplex PAthway SImulator","volume":"22","author":"Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1124\/dmd.118.081844_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/bmb\/ldl020","article-title":"Thiopurines, DNA damage, DNA repair and therapy-related cancer","volume":"79\u201380","author":"Karran","year":"2006","journal-title":"Br Med Bull"},{"key":"10.1124\/dmd.118.081844_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","article-title":"The clinical pharmacology of 6-mercaptopurine","volume":"43","author":"Lennard","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-4827(81)90192-0","article-title":"Differential chromatid damage induced by 6-thioguanine in CHO cells","volume":"135","author":"Maybaum","year":"1981","journal-title":"Exp Cell Res"},{"key":"10.1124\/dmd.118.081844_bib20","first-page":"3852","article-title":"Unilateral chromatid damage: a new basis for 6-thioguanine cytotoxicity","volume":"43","author":"Maybaum","year":"1983","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.118.081844_bib21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1470-2045(17)30154-7","article-title":"DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial","volume":"18","author":"Nielsen","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1124\/dmd.118.081844_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0006-2952(90)90494-6","article-title":"Characterization of the DNA damage in 6-thioguanine-treated cells","volume":"40","author":"Pan","year":"1990","journal-title":"Biochem Pharmacol"},{"issue":"D1","key":"10.1124\/dmd.118.081844_bib23","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkw952","article-title":"BRENDA in 2017: new perspectives and new tools in BRENDA","volume":"45","author":"Placzek","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.118.081844_bib24","series-title":"R: A Language and Environment for Statistical Computing","year":"2016"},{"key":"10.1124\/dmd.118.081844_bib25","doi-asserted-by":"crossref","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/dmd.118.081844_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.crohns.2012.12.006","article-title":"The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study","volume":"7","author":"Seinen","year":"2013","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1124\/dmd.118.081844_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.2008.154","article-title":"Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia","volume":"85","author":"Stocco","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.081844_bib28","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"key":"10.1124\/dmd.118.081844_bib29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/0006-2952(69)90069-0","article-title":"Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotides","volume":"18","author":"Tay","year":"1969","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":"CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.118.081844_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/dmd.118.081844_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0925-4439(93)90110-M","article-title":"The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts","volume":"1181","author":"Vogt","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.118.081844_bib33","first-page":"1670","article-title":"Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy","volume":"55","author":"Warren","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.118.081844_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1124\/mol.62.6.1321","article-title":"Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells","volume":"62","author":"Wielinga","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.081844_bib35","first-page":"433","article-title":"Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem\/progenitor cells: its therapeutic implication for MTAP (-) malignancies","volume":"3","author":"Yu","year":"1997","journal-title":"Clin Cancer Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624055910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.081844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:37:17Z","timestamp":1739903837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624055910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0090955624055910"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.081844","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three Faces of Mercaptopurine Cytotoxicity In Vitro: Methylation, Nucleotide Homeostasis, and Deoxythioguanosine in DNA","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.081844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}